{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T00:50:31Z","timestamp":1789865431446,"version":"4.0.1"},"reference-count":59,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1097\/iae.0b013e318074c290","type":"journal-article","created":{"date-parts":[[2009,3,3]],"date-time":"2009-03-03T23:30:03Z","timestamp":1236123003000},"page":"997-1003","source":"Crossref","is-referenced-by-count":105,"title":["IRON TOXICITY AS A POTENTIAL FACTOR IN AMD"],"prefix":"10.1097","volume":"27","author":[{"given":"ROBERT W.","family":"WONG","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D CHIMENE","family":"RICHA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PAUL","family":"HAHN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W RICHARD","family":"GREEN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JOSHUA L.","family":"DUNAIEF","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-1-20210130","first-page":"180","article-title":"Clinical aspects of ocular siderosis and hemosiderosis.","volume":"62","author":"Cibis","year":"1959","journal-title":"AMA Arch Ophthalmol"},{"key":"R2-1-20210130","doi-asserted-by":"crossref","first-page":"4660","DOI":"10.1167\/iovs.06-0568","article-title":"Iron induced oxidative damage as a potential factor in age-related macular degeneration: the Cogan Lecture.","volume":"47","author":"Dunaief","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R3-1-20210130","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0014-4835(69)80081-3","article-title":"Microsomal electron transfer system of bovine retinal pigment epithelium.","volume":"8","author":"Shichi","year":"1969","journal-title":"Exp Eye Res"},{"key":"R4-1-20210130","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0014-4835(79)90166-0","article-title":"An electron microscopic study of the permeability of intraocular blood vessels using lanthanum as a tracer in vivo.","volume":"29","author":"Pedersen","year":"1979","journal-title":"Exp Eye Res"},{"key":"R5-1-20210130","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1074\/jbc.M508903200","article-title":"RPE65 is an iron(II)-dependent isomerohydrolase in the retinoid visual cycle.","volume":"281","author":"Moiseyev","year":"2006","journal-title":"J Biol Chem"},{"key":"R6-1-20210130","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/jcp.1041520114","article-title":"Release of iron by human retinal pigment epithelial cells.","volume":"152","author":"Hunt","year":"1992","journal-title":"J Cell Physiol"},{"key":"R7-1-20210130","first-page":"2343","article-title":"Iron, ferritin, transferrin, and transferrin receptor in the adult rat retina.","volume":"41","author":"Yefimova","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R8-1-20210130","first-page":"598","article-title":"Immunolocalization and regulation of iron handling proteins ferritin and ferroportin in the retina.","volume":"10","author":"Hahn","year":"2004","journal-title":"Mol Vis"},{"key":"R9-1-20210130","first-page":"537","article-title":"Impaired retinal iron homeostasis associated with defective phagocytosis in Royal College of Surgeons rats.","volume":"43","author":"Yefimova","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R10-1-20210130","first-page":"182","article-title":"The relationship of age-related maculopathy, cataract, and glaucoma to visual acuity.","volume":"36","author":"Klein","year":"1995","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R11-1-20210130","first-page":"335","article-title":"The Framingham Eye Study monograph: An ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults, 1973\u20131975.","volume":"24","author":"Leibowitz","year":"1980","journal-title":"Surv Ophthalmol"},{"key":"R12-1-20210130","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0039-6257(00)00140-5","article-title":"The role of oxidative stress in the pathogenesis of age-related macular degeneration.","volume":"45","author":"Beatty","year":"2000","journal-title":"Surv Ophthalmol"},{"key":"R13-1-20210130","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1001\/archopht.122.4.598","article-title":"Current concepts in the pathogenesis of age-related macular degeneration.","volume":"122","author":"Zarbin","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"R14-1-20210130","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1001\/archopht.119.10.1417","article-title":"A randomized, placebo-controlled clinical trial of high-dose supplementation with vitamins c and e, beta carotene, and zinc for age-related macular degeneration and vision loss.","volume":"119","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"R15-1-20210130","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1001\/archopht.121.8.1099","article-title":"Maculas affected by age-related macular degeneration contain increased chelatable iron in the retinal pigment epithelium and Bruch's membrane.","volume":"121","author":"Hahn","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"R16-1-20210130","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0002-9394(99)00345-1","article-title":"Location, substructure, and composition of basal laminar drusen compared with drusen associated with aging and age-related macular degeneration.","volume":"129","author":"Russell","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"R17-1-20210130","doi-asserted-by":"crossref","first-page":"14682","DOI":"10.1073\/pnas.222551899","article-title":"Drusen proteome analysis: an approach to the etiology of age-related macular degeneration.","volume":"99","author":"Crabb","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"R18-1-20210130","doi-asserted-by":"crossref","first-page":"7227","DOI":"10.1073\/pnas.0501536102","article-title":"A common haplotype in the complement regulatory gene factor H (HF1\/CFH) predisposes individuals to age-related macular degeneration.","volume":"102","author":"Hageman","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"R19-1-20210130","doi-asserted-by":"crossref","first-page":"13850","DOI":"10.1073\/pnas.0405146101","article-title":"Disruption of ceruloplasmin and hephaestin in mice causes retinal iron overload and retinal degeneration with features of age-related macular degeneration.","volume":"101","author":"Hahn","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"R20-1-20210130","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1167\/iovs.05-1135","article-title":"The iron carrier transferrin is upregulated in retinas from patients with age-related macular degeneration.","volume":"47","author":"Chowers","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R21-1-20210130","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1097\/WNR.0b013e3280107776","article-title":"Iron levels in human retina: sex difference and increase with age.","volume":"17","author":"Hahn","year":"2006","journal-title":"Neuroreport"},{"key":"R22-1-20210130","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1124\/mi.6.2.6","article-title":"Iron dysregulation and neurodegeneration: the molecular connection.","volume":"6","author":"Lee","year":"2006","journal-title":"Mol Interv"},{"key":"R23-1-20210130","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1191\/1358863x03vm492ed","article-title":"Atherosclerosis: a manifestation of chronic iron toxicity?","volume":"8","author":"Zacharski","year":"2003","journal-title":"Vasc Med"},{"key":"R24-1-20210130","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1126\/science.1109557","article-title":"Complement factor H polymorphism in age-related macular degeneration.","volume":"308","author":"Klein","year":"2005","journal-title":"Science"},{"key":"R25-1-20210130","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1126\/science.1110189","article-title":"Complement factor H polymorphism and age-related macular degeneration.","volume":"308","author":"Edwards","year":"2005","journal-title":"Science"},{"key":"R26-1-20210130","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1126\/science.1110359","article-title":"Complement factor H variant increases the risk of age-related macular degeneration.","volume":"308","author":"Haines","year":"2005","journal-title":"Science"},{"key":"R27-1-20210130","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1371\/journal.pmed.0030005","article-title":"CFH Y402H confers similar risk of soft drusen and both forms of advanced AMD.","volume":"3","author":"Magnusson","year":"2005","journal-title":"PLoS Med"},{"key":"R28-1-20210130","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/0002-9394(82)90301-4","article-title":"Experimental subretinal hemorrhage in rabbits.","volume":"94","author":"Glatt","year":"1982","journal-title":"Am J Ophthalmol"},{"key":"R29-1-20210130","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/ng1750","article-title":"Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration.","volume":"38","author":"Gold","year":"2006","journal-title":"Nat Genet"},{"key":"R30-1-20210130","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1182\/asheducation-2006.1.29","article-title":"Hepcidin and its role in regulating systemic iron metabolism.","author":"Ganz","year":"2006","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"R31-1-20210130","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1159\/000463202","article-title":"Binding of iron to the 5th component of human complement directs oxygen radical-mediated conversion to specific sites and causes nonenzymic activation.","volume":"8","author":"Vogi","year":"1991","journal-title":"Complement Inflamm"},{"key":"R32-1-20210130","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3109\/02713689109001741","article-title":"Desferrioxamine ameliorates retinal photic injury in albino rats.","volume":"10","author":"Li","year":"1991","journal-title":"Curr Eye Res"},{"key":"R33-1-20210130","first-page":"E","article-title":"Deferoxamine reduced retinal toxicity from subretinal blood.","volume":"43","author":"Youssef","year":"2002","journal-title":"Invest Ophthalmol"},{"key":"R34-1-20210130","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/S0161-6420(86)33681-9","article-title":"Visual results and prognostic factors for vision following surgery for stage V retinopathy of prematurity.","volume":"93","author":"Trese","year":"1986","journal-title":"Ophthalmology"},{"key":"R35-1-20210130","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.ophtha.2004.12.029","article-title":"Macular degeneration in a patient with aceruloplasminemia, a disease associated with retinal iron overload.","volume":"112","author":"Dunaief","year":"2005","journal-title":"Ophthalmology"},{"key":"R36-1-20210130","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1073\/pnas.92.7.2539","article-title":"Aceruloplasminemia: molecular characterization of this disorder of iron metabolism.","volume":"92","author":"Harris","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"R37-1-20210130","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000027251","article-title":"Retinal degeneration in hereditary ceruloplasmin deficiency.","volume":"212","author":"Yamaguchi","year":"1998","journal-title":"Ophthalmologica"},{"key":"R38-1-20210130","doi-asserted-by":"crossref","first-page":"27144","DOI":"10.1074\/jbc.M301988200","article-title":"Glycosylphosphatidylinositol-anchored ceruloplasmin is required for iron efflux from cells in the central nervous system.","volume":"278","author":"Jeong","year":"2003","journal-title":"J Biol Chem"},{"key":"R39-1-20210130","first-page":"2693","article-title":"Apoptosis leads to photoreceptor degeneration in inherited retinal dystrophy of RCS rats.","volume":"35","author":"Tso","year":"1994","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R40-1-20210130","first-page":"91","article-title":"New knowledge of genetic pathogenesis of hemochromatosis and Wilson's disease.","volume":"44","author":"Bacon","year":"1999","journal-title":"Adv Intern Med"},{"key":"R41-1-20210130","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1073\/pnas.95.4.1472","article-title":"The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding.","volume":"95","author":"Feder","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"R42-1-20210130","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0092-8674(00)81151-4","article-title":"Crystal structure of the hemochromatosis protein HFE and characterization of its interaction with transferrin receptor.","volume":"93","author":"Lebron","year":"1998","journal-title":"Cell"},{"key":"R43-1-20210130","doi-asserted-by":"crossref","first-page":"8160","DOI":"10.1073\/pnas.161296298","article-title":"Hepcidin: a putative iron-regulatory hormone relevant to hereditary hemochromatosis and the anemia of chronic disease.","volume":"98","author":"Fleming","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"R44-1-20210130","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/archopht.1972.01000020509003","article-title":"Ocular pathologic changes in primary hemochromatosis.","volume":"87","author":"Roth","year":"1972","journal-title":"Arch Ophthalmol"},{"key":"R45-1-20210130","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1097\/00008480-200312000-00005","article-title":"Unraveling the Hallervorden-Spatz syndrome: pantothenate kinase-associated neurodegeneration is the name.","volume":"15","author":"Hayflick","year":"2003","journal-title":"Curr Opin Pediatr"},{"key":"R46-1-20210130","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0887-8994(01)00269-7","article-title":"Iron in the Hallervorden-Spatz syndrome.","volume":"25","author":"Koeppen","year":"2001","journal-title":"Pediatr Neurol"},{"key":"R47-1-20210130","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/0002-9394(79)90648-2","article-title":"Pigmentary degeneration of the retina in the Hallervorden-Spatz syndrome.","volume":"88","author":"Newell","year":"1979","journal-title":"Am J Ophthalmol"},{"key":"R48-1-20210130","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0002-9394(14)78308-4","article-title":"Ocular clinicopathologic correlation of Hallervorden-Spatz syndrome with acanthocytosis and pigmentary retinopathy.","volume":"95","author":"Luckenbach","year":"1983","journal-title":"Am J Ophthalmol"},{"key":"R49-1-20210130","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.bmc.2004.10.037","article-title":"Design, synthesis, and evaluation of novel bifunctional iron-chelators as potential agents for neuroprotection in Alzheimer's, Parkinson's, and other neurodegenerative diseases.","volume":"13","author":"Zheng","year":"2005","journal-title":"Bioorg Med Chem"},{"key":"R50-1-20210130","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1196\/annals.1306.026","article-title":"Novel chelators for central nervous system disorders that involve alterations in the metabolism of iron and other metal ions.","volume":"1012","author":"Richardson","year":"2004","journal-title":"Ann N Y Acad Sci"},{"key":"R51-1-20210130","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1136\/bjo.68.12.873","article-title":"Ocular changes in patients undergoing long-term desferrioxamine treatment.","volume":"68","author":"Arden","year":"1984","journal-title":"Br J Ophthalmol"},{"key":"R52-1-20210130","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0140-6736(83)90170-8","article-title":"Ocular toxicity of high-dose intravenous desferrioxamine.","volume":"2","author":"Davies","year":"1983","journal-title":"Lancet"},{"key":"R53-1-20210130","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0161-6420(84)34267-1","article-title":"Deferoxamine (Desferal)-induced toxic retinal pigmentary degeneration and presumed optic neuropathy.","volume":"91","author":"Lakhanpal","year":"1984","journal-title":"Ophthalmology"},{"key":"R54-1-20210130","first-page":"517","article-title":"The effect of deferoxamine, an iron chelator, on the morphology of the retina.","volume":"247","author":"Leure-duPree","year":"1987","journal-title":"Prog Clin Biol Res"},{"key":"R55-1-20210130","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0161-6420(01)00947-2","article-title":"The expanded clinical spectrum of deferoxamine retinopathy.","volume":"109","author":"Haimovici","year":"2002","journal-title":"Ophthalmology"},{"key":"R56-1-20210130","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0896-6273(03)00126-0","article-title":"Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson's disease.","volume":"37","author":"Kaur","year":"2003","journal-title":"Neuron"},{"key":"R57-1-20210130","first-page":"208","article-title":"Iron chelation by dibasic amino acid prevents glycoprotein insolubilities: a strategy to inhibit age-related macular degeneration?","volume":"4","author":"Waugh","year":"2004","journal-title":"J Appl Res"},{"key":"R58-1-20210130","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1067\/mhj.2000.106646","article-title":"Association of age, sex, and race with body iron stores in adults: analysis of NHANES III data.","volume":"140","author":"Zacharski","year":"2000","journal-title":"Am Heart J"},{"key":"R59-1-20210130","doi-asserted-by":"crossref","first-page":"4238","DOI":"10.1167\/iovs.06-0026","article-title":"Expression and polarized localization of the hemochromatosis gene product HFE in retinal pigment epithelium.","volume":"47","author":"Martin","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00006982-200710000-00001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,14]],"date-time":"2021-04-14T02:14:47Z","timestamp":1618366487000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006982-200710000-00001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":59,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0b013e318074c290","relation":{},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,10]]}}}